Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Breast Neoplasms 5Philadelphia Chromosome 4Leukemia 4Neoplasms 3Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid 2Bronchiolitis Obliterans Syndrome 2Translocation, Genetic 1Pathologic Processes 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Hematologic Diseases 1Bone Marrow Diseases 1Blast Crisis 1Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

bosutinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Breast Cancer (Parts 1 and 2) × bosutinib × Clear all
NCT00959946 2013-02-22

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Pfizer

Phase 1/2 Terminated
32 enrolled 15 charts
BreastCNSGastrointestinal

Advanced Breast Cancer (Parts 1 and 2)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡